🏛️ Company factsSEC filings + FINRA official data
Annual revenue $7.2B · latest quarter up 9.4% YoY · profitable (FY net income $849M) · short activity below its recent average — bears covering.
FY revenue
$7.2B
2025-12
Latest Q YoY
+9.4%
Gross margin
18.4%
FY net income
$849M
Diluted EPS
$2.21
Short volume
34.4%
20d avg 50.5% · shorts covering
🎯 Market expectations
Expectation reliability High · 78/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$3.69 vs $3.46+6.65%
- Mar 2026$2.60 vs $2.98-12.75%
- Dec 2025$4.47 vs $4.40+1.59%
- Sep 2025$3.19 vs $3.14+1.59%
The takeaway
It has tracked consensus closely — no systematic over- or under-shooting.
Analyst estimates, not our forecast · not investment advice
🧭 -8.6% today with no fresh news · why?
- 📊 Market-0.1%S&P -0.4% × beta 0.2
- 💸 Money flowMFI 24 · net outflow · volume 2.2× average — heavy
- 🔀 PeersMDT -1.2%ISRG -4.1%TSLA +3.9%9880.HK -1.1%NVDA -2.1%GOOGL -0.1%Peers are mixed today — this move looks more stock-specific.
- 🕰️ Old news, still digesting▲ Stryker Launches FDA-Cleared Apple Vision Pro Sustructural impact active, ~55 days left
- ❓ Remainder~-8.5% has no clear driver = market noise. Moves without reasons are normal — don't force a story.
Educational decomposition · not investment advice
What's moving this stock lately
No recent news affecting this stock
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
4 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →